Christopher Tucci

660 total citations
18 papers, 448 citations indexed

About

Christopher Tucci is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Christopher Tucci has authored 18 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Surgery and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Christopher Tucci's work include Bladder and Urothelial Cancer Treatments (4 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Christopher Tucci is often cited by papers focused on Bladder and Urothelial Cancer Treatments (4 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Christopher Tucci collaborates with scholars based in United States, Italy and India. Christopher Tucci's co-authors include Dwight T. Janerich, Sherry Chorost, M R Melamed, Muhammad Zaman, Michele Kiely, Peter Greenwald, Martin F. McKneally, W. Douglas Thompson, S. T. Mayne and MartinF. Mckneally and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Christopher Tucci

16 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Tucci United States 8 120 117 78 76 73 18 448
María‐Dolores Chirlaque Spain 15 93 0.8× 168 1.4× 41 0.5× 174 2.3× 80 1.1× 36 681
S. Komatsu Japan 12 75 0.6× 163 1.4× 71 0.9× 109 1.4× 75 1.0× 19 551
P. Boffetta United States 8 120 1.0× 110 0.9× 17 0.2× 134 1.8× 56 0.8× 10 822
Sherry Chorost United States 6 117 1.0× 130 1.1× 77 1.0× 114 1.5× 59 0.8× 8 540
Tsogzolmaa Dorjgochoo United States 15 52 0.4× 146 1.2× 86 1.1× 136 1.8× 35 0.5× 20 627
Ellen Graver United States 10 66 0.6× 44 0.4× 64 0.8× 162 2.1× 19 0.3× 11 478
Bong Yul Huh South Korea 12 61 0.5× 94 0.8× 33 0.4× 88 1.2× 49 0.7× 33 436
Terry Hartman United States 11 296 2.5× 248 2.1× 23 0.3× 163 2.1× 46 0.6× 18 605
Marko Bjelaković Serbia 7 83 0.7× 34 0.3× 42 0.5× 105 1.4× 38 0.5× 11 685
Lori Strayer United States 12 131 1.1× 134 1.1× 12 0.2× 103 1.4× 31 0.4× 21 530

Countries citing papers authored by Christopher Tucci

Since Specialization
Citations

This map shows the geographic impact of Christopher Tucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Tucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Tucci more than expected).

Fields of papers citing papers by Christopher Tucci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Tucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Tucci. The network helps show where Christopher Tucci may publish in the future.

Co-authorship network of co-authors of Christopher Tucci

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Tucci. A scholar is included among the top collaborators of Christopher Tucci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Tucci. Christopher Tucci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Tucci, Christopher, et al.. (2024). Lower urinary tract symptoms in elderly men: Considerations for prostate cancer testing. The Prostate. 84(14). 1290–1300.
2.
Tucci, Christopher, et al.. (2023). Defining Postoperative Early Ambulation for Reduced Length of Stay Following Robotic Urologic Surgery. Urologic Nursing. 43(3). 121–121.
3.
Tucci, Christopher, et al.. (2022). The state of PSA counseling in male‐to‐female transgender patients in the U.S.. The Prostate. 82(14). 1315–1321. 5 indexed citations
5.
Jankú, Filip, et al.. (2021). A multicenter open-label phase 1 study evaluating the safety and tolerability of HMPL-306 in patients with locally advanced or metastatic solid tumors with IDH mutations.. Journal of Clinical Oncology. 39(15_suppl). TPS3159–TPS3159. 1 indexed citations
6.
Paulson, Andrew Scott, Daneng Li, Max W. Sung, et al.. (2021). Interim analysis results of surufatinib in U.S. patients with neuroendocrine tumors (NETs).. Journal of Clinical Oncology. 39(15_suppl). 4114–4114. 3 indexed citations
7.
Dasari, Arvind, John Kauh, Christopher Tucci, et al.. (2021). An open-label phase 1b/2 study of surufatinib in combination with tislelizumab in subjects with advanced solid tumors.. Journal of Clinical Oncology. 39(15_suppl). TPS2677–TPS2677. 1 indexed citations
8.
Pereira, Jorge, et al.. (2020). The BMI Paradox and Robotic Assisted Partial Nephrectomy. Frontiers in Surgery. 6. 74–74. 10 indexed citations
9.
Dasari, Arvind, Daneng Li, Max W. Sung, et al.. (2020). Efficacy and safety of surufatinib in United States (US) patients (pts) with neuroendocrine tumors (NETs).. Journal of Clinical Oncology. 38(15_suppl). 4610–4610. 15 indexed citations
10.
Stoffel, John T., Kristin Chrouser, Jeffery S. Montgomery, et al.. (2020). Optimizing Outcomes in Urological Surgery: Preoperative Care. Urology Practice. 7(3). 205–211. 5 indexed citations
11.
Kim, Simon P., Ali Amin, Christopher Tucci, et al.. (2019). Clinically node-positive (cN+) urothelial carcinoma of the bladder treated with chemotherapy and radical cystectomy: Clinical outcomes and development of a postoperative risk stratification model. Urologic Oncology Seminars and Original Investigations. 38(3). 76.e19–76.e28. 12 indexed citations
12.
Brito, Joseph, Jorge Pereira, Daniel M. Moreira, et al.. (2018). The association of lymph node dissection with 30-day perioperative morbidity among men undergoing minimally invasive radical prostatectomy: analysis of the National Surgical Quality Improvement Program (NSQIP). Prostate Cancer and Prostatic Diseases. 21(2). 245–251. 6 indexed citations
13.
Pereira, Jorge, Gyan Pareek, Zheng Zhang, et al.. (2018). The Perioperative Morbidity of Transurethral Resection of Bladder Tumor: Implications for Quality Improvement. Urology. 125. 131–137. 23 indexed citations
15.
Tucci, Christopher, et al.. (1998). [Urologic complications of diverticulosis of the colon].. PubMed. 50(4). 261–5. 1 indexed citations
16.
Mayne, S. T., Dwight T. Janerich, Peter Greenwald, et al.. (1994). Dietary Beta Carotene and Lung Cancer Risk in U.S. Nonsmokers. JNCI Journal of the National Cancer Institute. 86(1). 33–38. 130 indexed citations
17.
Janerich, Dwight T., W. Douglas Thompson, Peter Greenwald, et al.. (1991). Lung cancer and exposure to tobacco smoke in the household. Journal of Safety Research. 22(2). 117–118. 21 indexed citations
18.
Janerich, Dwight T., W. Douglas Thompson, Peter Greenwald, et al.. (1990). Lung Cancer and Exposure to Tobacco Smoke in the Household. New England Journal of Medicine. 323(10). 632–636. 206 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026